EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Intradermal Injection of a Protein Alone Without Additional Adjuvants Using a Needle-Free Pyro-Drive Jet Injector Induces Potent CD8+ T Cell-Mediated Antitumor Immunity

Jukito Sonoda, Izuru Mizoguchi, Natsuki Yamaguchi, Eri Horio, Satomi Miyakawa, Mingli Xu iD, Toshihiko Yoneto, Yasuhiro Katahira iD, Hideaki Hasegawa, Takashi Hasegawa, Kunihiko Yamashita, Takayuki Yoshimoto iD

International Journal of Molecular Sciences · 07.05.2025 · 26 (9) · 4442

DOI: 10.3390/ijms26094442 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 07.05.2025. Verfasst von Jukito Sonoda und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunoregulation, Institute of Medical Science, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, Japan. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Ovalbumin, Cancer Vaccines, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan, Daicel Corporation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vaccines usually contain an adjuvant that activates innate immunity to promote the acquisition of adaptive immunity. Aluminum and lipid nanoparticles have been used for this purpose, but their accumulation or widespread circulation in the body can lead to adverse effects. In contrast, physical adjuvants, which use physical energy to transiently stress tissues, do not persist in exposed tissues or cause lasting adverse effects. Herein, we investigate the effects of intradermal injection of endotoxin-free ovalbumin (OVA) protein alone without additional adjuvants using a needle-free pyro-drive jet injector (PJI) on tumor vaccination efficacy. Intradermal injection of OVA protein alone using PJI significantly increased OVA-specific CD8+ T cell expansion in the lymph node, although lymph node swelling was much less than when aluminum hydroxide was used. The injection also induced OVA-specific killing activity and antibody production and showed strong CD8+ T cell-dependent prophylactic antitumor effects against transplanted E.G7-OVA tumors. In particular, intradermal injection of the fluorescent OVA protein significantly enhanced its uptake by XCR1+ dendritic cells, which have a strong ability to cross-present extracellular proteins in the skin and draining lymph nodes. In addition, the injection increased the expression of HMGB1, one of the potent danger signals whose expression has been reported to increase in response to shear stress. Thus, intradermal injection of OVA protein alone without any additional adjuvants using PJI induces potent CD8+ T cell-mediated antitumor immunity by enhancing its uptake into XCR1+ dendritic cells, which have a high cross-presentation capacity accompanied by an increased expression of shear stress-induced HMGB1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD8-Positive T-LymphocytesOvalbuminCancer VaccinesNeoplasmsAnimalsInjections, IntradermalMiceMice, Inbred C57BLAdjuvants, ImmunologicFemaleDendritic Cells

Stichwörter der Autor:innen

cancer vaccinegeneration of CTLphysical adjuvantpyro-drive jet injectorshear stress

Substanzen

OvalbuminCancer VaccinesAdjuvants, Immunologic

Autor:innen und Institutionen

  • Department of Immunoregulation, Institute of Medical Science, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, Japan.
  • Department of Device Application for Molecular Therapeutics, Graduate School of Medicine, Osaka University, CoMIT 0603, 2-2 Yamada-oka, Suita 565-0871, Osaka, Japan.
  • Medical Device Division, Life Sciences Strategic Business Unit, Daicel Corporation, 2-2 Yamada-oka, Suita 565-0871, Osaka, Japan.

ORCID-Profile: Mingli Xu, Yasuhiro Katahira, Takayuki Yoshimoto

Förderung

  • Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan
  • Daicel Corporation

Zitieren

APA

Sonoda, J., Mizoguchi, I., Yamaguchi, N., Horio, E., Miyakawa, S., Xu, M., Yoneto, T., Katahira, Y., Hasegawa, H., Hasegawa, T., Yamashita, K., & Yoshimoto, T. (2025). Intradermal Injection of a Protein Alone Without Additional Adjuvants Using a Needle-Free Pyro-Drive Jet Injector Induces Potent CD8+ T Cell-Mediated Antitumor Immunity. International Journal of Molecular Sciences, 26(9), 4442. https://doi.org/10.3390/ijms26094442

Vancouver

Sonoda J, Mizoguchi I, Yamaguchi N, Horio E, Miyakawa S, Xu M, et al. Intradermal Injection of a Protein Alone Without Additional Adjuvants Using a Needle-Free Pyro-Drive Jet Injector Induces Potent CD8+ T Cell-Mediated Antitumor Immunity. International Journal of Molecular Sciences. 2025;26(9):4442. doi:10.3390/ijms26094442

BibTeX
@article{Sonoda2025,
  author = {Sonoda, Jukito and Mizoguchi, Izuru and Yamaguchi, Natsuki and Horio, Eri and Miyakawa, Satomi and Xu, Mingli and Yoneto, Toshihiko and Katahira, Yasuhiro and Hasegawa, Hideaki and Hasegawa, Takashi and Yamashita, Kunihiko and Yoshimoto, Takayuki},
  title = {Intradermal Injection of a Protein Alone Without Additional Adjuvants Using a Needle-Free Pyro-Drive Jet Injector Induces Potent CD8+ T Cell-Mediated Antitumor Immunity},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {9},
  pages = {4442},
  doi = {10.3390/ijms26094442}
}
Kostenlos starten →